Mental Disorder
9 drugs2,454 FAERS reportsMedDRA PT
GET
/api/v1/reaction/mental-disorderReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
DefinitionNLM MeSH D001523
Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function.
Source: U.S. National Library of Medicine — MeSH (Mental Disorders)
Drugs reporting Mental Disorder (9)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Helicobacter Pylori2743%
- 2Cystine133%
- 3Acetylcholine3329%
- 4Tafenoquine1014%
- 5Deutivacaftor153.1%
- 6Vanzacaftor153.1%
- 7Elexacaftor3292.7%
- 8Tezacaftor3502.0%
- 9Hydrocodone1,6741.7%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Cystic Fibrosis4 shared · 0.24
- Infective Pulmonary Exacerbation Of Cystic Fibrosis4 shared · 0.22
- Productive Cough6 shared · 0.21
- Obstruction2 shared · 0.20
- Sinus Disorder2 shared · 0.20
- Respiratory Disorder2 shared · 0.15
- Mental Impairment2 shared · 0.14
- Sleep Disorder Due To A General Medical Condition2 shared · 0.14
- Brain Fog2 shared · 0.13
- Eosinophilia2 shared · 0.09
Literature
Recent PubMed references pinned to Mental Disorders as a MeSH major topic. About the reaction term itself — not about any specific drug.
- Test-Retest Reliability of Standardized Diagnostic Interviews for Common Adult Psychiatric Disorders: A Systematic Review and Meta-Analysis.JAMA network open · 2026 · Xie W, Nordgaard J, Sheldrick RC, et al.PMID 42207515DOI 10.1001/jamanetworkopen.2026.15039
- High-Deductible Health Plan Enrollment and Buprenorphine Dispensing.JAMA network open · 2026 · Chua KP, Bohnert AS, Conti RM, et al.PMID 42207512DOI 10.1001/jamanetworkopen.2026.15550
- Intermittent Fasting Attenuates Cognitive Decline in D-Galactose-Induced Aging Rats in Association with β-Hydroxybutyrate and PI3K/AKT/GSK-3β Signaling.Neurochemical research · 2026 · Lin X, Huang L, Ling X, et al.PMID 42207407DOI 10.1007/s11064-026-04804-9
- ADHD and the female reproductive stages: menstruation, perinatal and menopause.Archives of women's mental health · 2026 · Boyd C, Wrigley M, Kilbride K, et al.PMID 42207323DOI 10.1007/s00737-026-01718-x
- Erythrina caffra extract restores memory, modulates cholinergic dysfunction, neuroinflammation, and attenuates oxidative stress in cadmium-induced alzheimer's disease-like pathology in rats.Molecular biology reports · 2026 · Ed-Day S, Kacimi FE, El Gui R, et al.PMID 42207225DOI 10.1007/s11033-026-12036-x
- Transient Receptor Potential Channels in Modulating Synaptic Plasticity and Cognitive Function: Potential Role of Pharmacological Agents.Basic & clinical pharmacology & toxicology · 2026 · Sarkar A, Srinivasan K, Datusalia AK, et al.PMID 42206888DOI 10.1111/bcpt.70248
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.